Please login to the form below

Not currently logged in
Email:
Password:

Ashfield promotes Tom Mitchell to UK head of syndicated services

He first joined the UDG Healthcare division in 2008 as a regional business manager

Tom MitchellUDG Healthcare’s commercialisation service division Ashfield has appointed Tom Mitchell as head of syndicated services for the UK.

Mitchell joined the Ashfield commercial business in 2008 as its regional business manager (RBM) as part of the Apex syndicated team before taking on a role as project manager for the newly-formed Discovery syndicated team in 2010.

He said: “I am thrilled to be leading the development of our syndicated services, with so many highly skilled representatives in our established teams.

“The experience, productivity and in-call quality scores of our people mean clients can be proud to have them represent their brands.

“I look forward to working closely with our clients to further develop our syndicated sales solutions and the benefits that we can bring to their brands for many years to come.”

With over 28 years of experience, Mitchell has held numerous senior level roles such as medical representative, primary and secondary care RBM, and project manager among others.

Colin Watson, managing director of Ashfield, said: “Tom has a really important role to maintain our operational excellence, high quality sales calls, and close working partnership with our clients in order to deliver on their brand objectives.”

27th April 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics